Pfizer Stays Engaged With Authorities in Karnataka Fake Drug Investigation
Pfizer says it is working with authorities to resolve open queries in a fake drug probe in Karnataka, with patient safety as its priority.
Pfizer has said it remains in close coordination with authorities handling an investigation into counterfeit drugs in Karnataka, as questions connected to the case are yet to be fully resolved.
The company said its overriding concern is the protection of patients, the safeguarding of public health and the preservation of confidence in the healthcare system.
According to the drugmaker, it is continuing to work with the relevant agencies to address the outstanding queries linked to the probe. It did not specify the nature of those queries or the stage the investigation has reached.
The case centres on fake medicines in Karnataka, a matter that has drawn attention to the risks counterfeit pharmaceuticals pose to patients and to the wider trust placed in drug supply chains.
Pfizer's statement places patient welfare at the centre of its response, framing its engagement with investigators as part of that commitment. The company has not disclosed further details about the investigation or its own role in the matter.